Loading…
LifeVantage Corporation is projected to rise to $9.79 by 2027, a +22% move from its current price of $8.05. LFVN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.65 | $8.05 | $8.48 | +0.04% |
| May 30 | $7.49 | $8.06 | $8.67 | +0.09% |
| May 31 | $7.37 | $8.06 | $8.81 | +0.13% |
| Jun 1 | $7.27 | $8.06 | $8.94 | +0.17% |
| Jun 2 | $7.19 | $8.07 | $9.06 | +0.21% |
| Jun 3 | $7.11 | $8.07 | $9.16 | +0.26% |
| Jun 4 | $7.04 | $8.07 | $9.26 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.04 | $8.07 | $9.26 | +0.30% |
| Week 2 | $6.67 | $8.10 | $9.83 | +0.60% |
| Week 3 | $6.41 | $8.12 | $10.29 | +0.90% |
| Week 4 | $6.20 | $8.15 | $10.71 | +1.20% |
| Week 5 | $6.02 | $8.17 | $11.09 | +1.51% |
| Week 6 | $5.86 | $8.20 | $11.46 | +1.81% |
| Week 7 | $5.73 | $8.22 | $11.80 | +2.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeVantage Corporation is a consumer defensive company focused on nutrigenomic activators and a broad range of dietary supplements, nootropics, weight management products, pre- and pro-biotics, and skin and hair care items sold internationally.
Its product lineup includes Protandim, LifeVantage Omega+, LifeVantage ProBio, IC Bright, LifeVantage Daily Wellness, Rise AM and Reset PM, LifeVantage D3+, PhysIQ Fat Burn, PhysIQ Prebiotic, MindBody GLP-1 System, Petandim for Dogs, Axio, and TrueScience skincare products such as cleansers, moisturizers, sunscreen, and hand creams.
The company markets these products through its website and a network of independent consultants and is based in Lehi, Utah.
LifeVantage Corporation (LFVN) is currently priced at $8.05 per share with a market capitalization of $101.56M.
Its rank among listed stocks is 4175.
A long-run price outlook from the provided forecast shows upside potential, with an average price forecast rising to $13.11 by 2030 and $77.57 by 2050, including a max forecast of $22.60 in 2030 and $178.41 in 2050.
The forecast also notes bullish sentiment in later years, with ROI values such as 21.6 in 2027, 62.8 in 2030, 110.9 in 2031, 407.4 in 2040, and 863.6 in 2050.
A major floor 61.3% below — a decisive break under it would weaken the trend.
The nearest floor, 46.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 30.6% above — clearing it would confirm fresh momentum.
Key LFVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.24 | Buy | $6.62 | Buy |
| MA 10 | $5.72 | Buy | $6.05 | Buy |
| MA 20 | $5.50 | Buy | $5.63 | Buy |
| MA 50 | $4.92 | Buy | $5.26 | Buy |
| MA 100 | $5.16 | Buy | $5.60 | Buy |
| MA 200 | $7.12 | Buy | $7.01 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 80.66 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 370.55 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 50.75 | Buy |
| Bollinger %B (20,2) | 1.38 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 1.07 | Buy |
| Ultimate (7,14,28) | 87.62 | Sell |
| Momentum (10) | 2.90 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 6.95 | Buy |
| ADX (14) | 20.05 | Buy |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is bullish, with RSI14 at 80.
The stock trades above its SMA50 of $4.92 and above its SMA200 of $7.12, with a defined near-term support at $4.35 and resistance at $8.05. The 30-day price range runs from $5.73 to $11.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.02 | $8.05 | $11.08 | 0% | Neutral | |
| $7.09 | $9.79 | $14.61 | +22% | Bullish | |
| $6.34 | $9.26 | $14.68 | +15% | Neutral | |
| $6.15 | $9.44 | $15.66 | +17% | Neutral | |
| $8.17 | $13.11 | $22.60 | +63% | Bullish | |
| $10.14 | $16.98 | $30.26 | +111% | Bullish | |
| $11.40 | $19.86 | $36.47 | +147% | Bullish | |
| $11.73 | $21.23 | $40.03 | +164% | Bullish | |
| $11.62 | $21.83 | $42.17 | +171% | Bullish | |
| $11.44 | $22.29 | $44.04 | +177% | Bullish | |
| $18.38 | $40.85 | $88.48 | +407% | Bullish | |
| $34.91 | $77.57 | $178.41 | +864% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.02 | $8.05 | $9.54 | +0.00% |
| June 2026 | $6.88 | $8.24 | $10.22 | +2.36% |
| July 2026 | $6.88 | $8.37 | $10.64 | +1.57% |
| August 2026 | $6.45 | $7.95 | $10.30 | -4.99% |
| September 2026 | $6.31 | $7.86 | $10.33 | -1.14% |
| October 2026 | $6.62 | $8.33 | $11.10 | +5.95% |
| November 2026 | $6.62 | $8.40 | $11.33 | +0.84% |
| December 2026 | $6.35 | $8.13 | $11.08 | -3.23% |
Click any year to see its month-by-month LFVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LifeVantage Corporation's 2026 outlook centres on $8.05, within a $4.02 to $11.08 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, LFVN could reach as high as $14.61, with a base case around $9.79 and support toward $7.09 — roughly +22% from $8.05. Momentum favours further upside here.
Expect LFVN to range from $6.34 to $14.68 through 2028. The $9.26 average target implies a +15% move from current prices. That is -5% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The LFVN price prediction for 2029 points to an average of $9.44 (low $6.15, high $15.66) — a potential gain of +17% on today's $8.05. Price action looks broadly range-bound.
In 2030, LFVN is projected to trade between $8.17 and $22.60, averaging $13.11 — a potential gain of +63% from today's $8.05. That is up +39% on the projected 2029 average. Buyers look set to stay in control over this stretch.
LifeVantage Corporation's 2031 outlook centres on $16.98, within a $10.14 to $30.26 range. That is up +30% on the projected 2030 average. That marks a +111% change versus current levels. Momentum favours further upside here.
By 2032, LFVN could reach as high as $36.47, with a base case around $19.86 and support toward $11.40 — roughly +147% from $8.05. Buyers look set to stay in control over this stretch.
Expect LFVN to range from $11.73 to $40.03 through 2033. The $21.23 average target implies a +164% move from current prices. That is up +7% on the projected 2032 average. Momentum favours further upside here.
The LFVN price prediction for 2034 points to an average of $21.83 (low $11.62, high $42.17) — a potential gain of +171% on today's $8.05. Buyers look set to stay in control over this stretch.
In 2035, LFVN is projected to trade between $11.44 and $44.04, averaging $22.29 — a potential gain of +177% from today's $8.05. That is up +2% on the projected 2034 average. Momentum favours further upside here.
LifeVantage Corporation's 2040 outlook centres on $40.85, within a $18.38 to $88.48 range. That is up +83% on the projected 2035 average. That marks a +407% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, LFVN could reach as high as $178.41, with a base case around $77.57 and support toward $34.91 — roughly +864% from $8.05. Momentum favours further upside here.
Investing $1,000 in LFVN today (≈ 124.223602 LFVN) could be worth
$9,635.88
+$8,635.88 (+864%) by 2050 · US Dollar
Based on the average projected LFVN price of $77.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFVNwould be worth at today's price.
$1,000 invested in LFVN on May 27, 2025 (≈ 74.794316 LFVN) would be worth
$602.09
-$397.91 (-39.8%) today · 0.60× · US Dollar
Based on a LFVN entry price of $13.37 vs. today's $8.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.25 | $1,533.33 | +53.3% |
| 1 month ago | $5.51 | $1,460.98 | +46.1% |
| 3 months ago | $4.68 | $1,720.09 | +72.0% |
| 6 months ago | $6.87 | $1,171.76 | +17.2% |
| 1 year ago | $13.37 | $602.09 | -39.8% |
| All time (5.0y) ago | $7.96 | $1,011.31 | +1.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFVN forecast.
Our base-case forecast reaches $16.00 around 2031.
Implied market cap at $16.00: $201.85M
The multi-year forecast shows sustained upside, with the average price extending from $8.05 in 2026 to $13.11 in 2030 and $77.57 in 2050. The max forecasts rise to $22.60 in 2030 and $178.41 in 2050, underscoring substantial upside potential.
Bullish sentiment appears in 2027 (avg $9.79, ROI 21.6) and remains through 2030, 2031, and beyond (2030 avg $13.11, ROI 62.8; 2031 avg $16.98, ROI 110.9; 2040 avg $40.85, ROI 407.4; 2050 avg $77.57, ROI 863.6).
These figures are estimates and not guarantees, and the asset may experience high volatility, as reflected by an annualized volatility of 100%.
Overall, the forecast indicates upside potential with higher average prices in the later years, reaching a max of $22.60 in 2030, $88.48 in 2040, and $178.41 in 2050.
Tap a question to reveal the answer.
2030 min $8.17, avg $13.11, max $22.60 with ROI 62.8 and sentiment BULLISH.
The forecast shows a bullish trajectory from 2027 onward, with 2027 avg $9.79 (ROI 21.6) and 2030 avg $13.11 (ROI 62.8), 2040 avg $40.85 (ROI 407.4), and 2050 avg $77.57 (ROI 863.6). Note these are estimates, not guarantees.
Yes, the max forecast reaches $88.48 by 2040 and $178.41 by 2050, while 2030 max is $22.60. A $50 level could be reached in 2040 or later according to the projections.
Current price is $8.05 and market cap is $101.56M. Its rank is 4175.
RSI14 is 80. The stock trades above SMA50 of $4.92 and SMA200 of $7.12, with near-term support at $4.35 and resistance at $8.05. The 30-day range is $5.73 to $11.32.
LifeVantage Corporation Community Discussion
0Share your LifeVantage Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.